FR2500753B1 - Glycoproteine ayant une activite biologique, procede pour la preparer et compositions pharmaceutiques immunoactives la contenant - Google Patents

Glycoproteine ayant une activite biologique, procede pour la preparer et compositions pharmaceutiques immunoactives la contenant

Info

Publication number
FR2500753B1
FR2500753B1 FR8203326A FR8203326A FR2500753B1 FR 2500753 B1 FR2500753 B1 FR 2500753B1 FR 8203326 A FR8203326 A FR 8203326A FR 8203326 A FR8203326 A FR 8203326A FR 2500753 B1 FR2500753 B1 FR 2500753B1
Authority
FR
France
Prior art keywords
same
immunoactive
glycoprotein
pharmaceutical compositions
biological activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8203326A
Other languages
English (en)
Other versions
FR2500753A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56028553A external-priority patent/JPS57144983A/ja
Priority claimed from JP56028554A external-priority patent/JPS57142922A/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of FR2500753A1 publication Critical patent/FR2500753A1/fr
Application granted granted Critical
Publication of FR2500753B1 publication Critical patent/FR2500753B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR8203326A 1981-02-27 1982-03-01 Glycoproteine ayant une activite biologique, procede pour la preparer et compositions pharmaceutiques immunoactives la contenant Expired FR2500753B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56028553A JPS57144983A (en) 1981-02-27 1981-02-27 Preparation of physiologically active substance
JP56028554A JPS57142922A (en) 1981-02-27 1981-02-27 Physiologically active substance and immuno-activating agent

Publications (2)

Publication Number Publication Date
FR2500753A1 FR2500753A1 (fr) 1982-09-03
FR2500753B1 true FR2500753B1 (fr) 1985-09-27

Family

ID=26366680

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8203326A Expired FR2500753B1 (fr) 1981-02-27 1982-03-01 Glycoproteine ayant une activite biologique, procede pour la preparer et compositions pharmaceutiques immunoactives la contenant

Country Status (10)

Country Link
US (1) US4482543A (fr)
AR (1) AR232003A1 (fr)
AU (1) AU549856B2 (fr)
CA (1) CA1186629A (fr)
CH (1) CH657989A5 (fr)
DE (1) DE3207019A1 (fr)
FR (1) FR2500753B1 (fr)
GB (1) GB2095260B (fr)
NL (1) NL8200797A (fr)
NZ (1) NZ199752A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2570670B2 (ja) * 1987-12-28 1997-01-08 味の素株式会社 トキソプラズマ増殖抑制剤
JPH0474197A (ja) * 1990-07-12 1992-03-09 Naoyoshi Suzuki 新規な免疫調整生理活性ペプチド
US5622852A (en) * 1994-10-31 1997-04-22 Washington University Bcl-x/Bcl-2 associated cell death regulator
BG65084B1 (bg) * 2002-03-13 2007-02-28 Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А" Нов клас биоактивни гликопротеини
US6958039B2 (en) 2003-05-02 2005-10-25 Oculir, Inc. Method and instruments for non-invasive analyte measurement
US6968222B2 (en) 2003-05-02 2005-11-22 Oculir, Inc. Methods and device for non-invasive analyte measurement
US6975892B2 (en) * 2003-10-21 2005-12-13 Oculir, Inc. Methods for non-invasive analyte measurement from the conjunctiva
CN107789647B (zh) * 2016-09-05 2021-02-02 上海赛伦生物技术股份有限公司 一种灭活动物血清或血浆中病毒的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
JPS536412A (en) * 1976-07-07 1978-01-20 Kureha Chem Ind Co Ltd Preparation of n-containing polysaccharides
JPS56145297A (en) * 1980-04-11 1981-11-11 Kureha Chem Ind Co Ltd Preparative method of glycoprotein having immunosupressing activity

Also Published As

Publication number Publication date
NZ199752A (en) 1984-11-09
CA1186629A (fr) 1985-05-07
GB2095260A (en) 1982-09-29
NL8200797A (nl) 1982-09-16
CH657989A5 (de) 1986-10-15
AU8053582A (en) 1982-09-02
AU549856B2 (en) 1986-02-20
US4482543A (en) 1984-11-13
GB2095260B (en) 1984-07-18
DE3207019A1 (de) 1982-09-16
FR2500753A1 (fr) 1982-09-03
AR232003A1 (es) 1985-04-30

Similar Documents

Publication Publication Date Title
NL190757C (nl) 4-(3-Chloorfenyl)-1-piperazinylpropyl gesubstitueerde-1,2,4-triazool-3-on verbindingen met antidepressieve werking en farmaceutische preparaten daarvan.
NL930039I2 (nl) Derivaten van cis, endo-2-azabicyclo-(3,3,0)-octaan-3-carbonzuur, werkwijze voor de bereiding daarvan, deze stoffen bevattende middelen en hun toepassing.
FR2569691B1 (fr) Derives de benzimidazole, procede pour les preparer et agents anti-ulcereux les contenant
FR2594438B1 (fr) Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
FR2595351B1 (fr) Derives d'indole, procede pour leur preparation et compositions pharmaceutiques les contenant
BE890574A (fr) Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant
FR2599027B1 (fr) Derives de tetrahydronaphtalene et d'indane, utilisation pour la fabrication de preparations pharmaceutiques et procede d'obtention.
FR2553099B1 (fr) Fractions d'acide hyaluronique ayant une activite pharmaceutique, procedes pour leur preparation et compositions pharmaceutiques les contenant
PT78340B (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
FR2599034B1 (fr) Derives de 1-(hydroxystyryl)-5h-2,3,-benzodiazepine, procede pour les preparer et compositions pharmaceutiques les contenant
FR2569702B1 (fr) Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation
FR2500753B1 (fr) Glycoproteine ayant une activite biologique, procede pour la preparer et compositions pharmaceutiques immunoactives la contenant
OA07925A (fr) Produit alimentaire efficace dans le traitement de la lèpre.
FR2628419B1 (fr) Nouveaux sels antiviraux, compositions pharmaceutiques les contenant et procede pour les preparer
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2726267B1 (fr) Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer
FR2595705B1 (fr) Derives de gonadoliberine contenant un acide aminocarboxylique aromatique en position 6, compositions pharmaceutiques et veterinaires les contenant et procede pour les preparer
FR2580649B1 (fr) (-) - 1b - ethyl - 1a - hydroxymethyl -1,2,3,4,6,7,12,12ba-octahydroindolo(2,3-a) quinolizine, procede pour la preparer et compositions pharmaceutiques contenant celle-ci
FR2615188B1 (fr) Derives d'hydrazine, procede d'obtention et compositions pharmaceutiques les contenant
FR2547821B1 (fr) Sel de 2-piperazinopyrimidine, procede pour sa preparation et compositions pharmaceutiques en contenant
FR2605623B1 (fr) Procede de preparation de particules magnetiques d'hexaferrites, particules obtenues et produits les contenant
PT77767B (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
IT1168163B (it) Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative
FR2543546B1 (fr) Derives de gonadoreline contenant un groupe b-aspartyle, procede pour leur preparation et preparations pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse